Request Your Free On-Demand Webinar Now:

"HIV Molecular Diagnostics in the PrEP Era: A Stakeholder Conversation"

In this on-demand GenomeWebinar, sponsored by Hologic, a panel of experts in HIV patient care and molecular diagnostics critically reviews the current molecular screening guidelines for people on PrEP, discusses various types of available HIV testing methods and the role they play in testing prior to and during PrEP, and addresses ways to increase access to PrEP and associated testing requirements.

In the decade since it was introduced, pre-exposure prophylaxis, or PrEP, has revolutionized care for people at risk of acquiring HIV infection. However, PrEP medications can prevent the HIV virus from replicating and slow antibody development, potentially delaying diagnosis if a person does become infected. Detecting an early HIV infection before initiating PrEP is also critical in order to prevent the possibility of the medication applying a selective pressure that leads to antiretroviral resistance.

Offered Free by: Hologic
See All Resources from: Hologic